Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer
Clinical trial NCT03620435 · UNKNOWN
Trial details
- NCT number
- NCT03620435
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2020-05-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.